FOSTER CITY, Calif.-- -- Gilead Sciences, Inc. today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches: The senior notes are rated A- by Standard & Poor's and A3 by Moody's. The offering is expected to close November 17, 2014, subject to customary closing conditions.